4//SEC Filing
Hasnain Faheem 4
Accession 0001352620-25-000004
CIK 0001728117other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:13 PM ET
Size
5.6 KB
Accession
0001352620-25-000004
Insider Transaction Report
Form 4
Hasnain Faheem
DirectorPresident & CEO
Transactions
- Award
Common Stock
2025-10-01+437,500→ 557,793 total
Holdings
- 5,408,073(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Represents performance stock unit award, which will vest in full upon the earlier of (i) the approval of a new drug application for seralutinib or (ii) a change in control, in either case on or prior to the fourth anniversary of the grant date, and subject to the Reporting Person's continuous service to the Issuer.
Documents
Issuer
Gossamer Bio, Inc.
CIK 0001728117
Entity typeother
Related Parties
1- filerCIK 0001352620
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 4:13 PM ET
- Size
- 5.6 KB